RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$1.07B
1-Year Est. Return
44.45%
This Fund
S&P 500
1 Year Est. Return
+44.45%
AUM
$1.07B
AUM Growth
+$166M
(+18%)
Holding
105
Top Buys
| 1 | +$17.2M | |
| 2 | +$13.3M | |
| 3 | +$11.4M | |
| 4 |
Nuvalent
NUVL
|
+$10.9M |
| 5 |
Vera Therapeutics
VERA
|
+$10.3M |
Top Sells
| 1 | +$19M | |
| 2 | +$14.8M | |
| 3 | +$13.2M | |
| 4 |
Cytokinetics
CYTK
|
+$13.1M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$11.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Regeneron Pharmaceuticals
REGN
$81.6B
| $47.4M | 4.43% |
61,400
+25,300
|
|
||
2
Eli Lilly
LLY
$894B
| $45.4M | 4.24% |
42,220
-11,200
|
|
||
3
Boston Scientific
BSX
$104B
| $41.1M | 3.84% |
431,207
-6,793
|
|
||
4
Medtronic
MDT
$115B
| $28.4M | 2.66% |
296,000
+91,000
|
|
||
5
Intuitive Surgical
ISRG
$173B
| $27.2M | 2.54% |
48,000
-500
|
|
||
6
Cooper Companies
COO
$14.5B
| $26.8M | 2.51% |
327,500
+90,500
|
|
||
7
CVS Health
CVS
$97.1B
| $26.6M | 2.49% |
335,500
+58,138
|
|
||
8
AbbVie
ABBV
$401B
| $25.3M | 2.36% |
110,575
-19,800
|
|
||
9
Glaukos
GKOS
$5.99B
| $23.7M | 2.22% |
210,000
-20,000
|
|
||
10
Danaher
DHR
$138B
| $22.7M | 2.12% |
99,052
-35,400
|
|
||
11
Cencora
COR
$68.5B
| $21.4M | 2% |
63,375
+1,000
|
|
||
|
12
Vera Therapeutics
VERA
$2.87B
| $21.3M | 1.99% |
420,000
+290,000
|
|
||
13
McKesson
MCK
$114B
| $21M | 1.96% |
25,600
-1,000
|
|
||
14
Axsome Therapeutics
AXSM
$8.51B
| $21M | 1.96% |
114,800
-58,000
|
|
||
15
Alignment Healthcare
ALHC
$3.7B
| $19.9M | 1.86% |
1,009,450
-469,834
|
|
||
16
Insmed
INSM
$31B
| $19.8M | 1.85% |
113,585
-18,300
|
|
||
17
Thermo Fisher Scientific
TMO
$186B
| $19.5M | 1.82% |
33,640
+3,600
|
|
||
18
Procept Biorobotics
PRCT
$1.36B
| $19.2M | 1.8% |
611,000
+221,000
|
|
||
19
Alnylam Pharmaceuticals
ALNY
$42.8B
| $18.2M | 1.7% |
45,675
+13,800
|
|
||
20
UnitedHealth
UNH
$256B
| $18.1M | 1.69% |
54,900
-7,630
|
|
||
21
Neurocrine Biosciences
NBIX
$13B
| $17.8M | 1.66% |
125,491
+10,774
|
|
||
22
Insulet
PODD
$16.8B
| $17.3M | 1.62% |
61,000
+3,000
|
|
||
23
Doximity
DOCS
$4.58B
| $16.5M | 1.54% |
372,750
+236,750
|
|
||
24
Edwards Lifesciences
EW
$49.8B
| $16.5M | 1.54% |
193,500
+38,500
|
|
||
|
25
Nuvalent
NUVL
$8.04B
| $16.4M | 1.54% |
163,350
+110,850
|
|